Published in Nat Rev Cancer on August 01, 2004
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 26.09
Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol (2009) 10.18
Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell (2010) 8.04
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature (2013) 7.51
Diabetes and cancer: a consensus report. Diabetes Care (2010) 6.71
Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov (2011) 5.79
Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell (2010) 5.47
Epidemiology and risk factors for kidney cancer. Nat Rev Urol (2010) 5.25
Influence of tumour micro-environment heterogeneity on therapeutic response. Nature (2013) 4.78
Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology (2009) 4.72
Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol (2014) 4.00
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA (2009) 3.86
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer (2012) 3.55
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer (2010) 3.27
Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer. Hepatology (2014) 3.06
MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes (2009) 3.02
Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res (Phila) (2011) 2.97
Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34. Cell Metab (2008) 2.96
The microbiome and cancer. Nat Rev Cancer (2013) 2.86
Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol (2008) 2.63
High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. Nature (2016) 2.50
Cellular metabolic stress: considering how cells respond to nutrient excess. Mol Cell (2010) 2.50
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood (2008) 2.49
The metabolic syndrome: A high-risk state for cancer? Am J Pathol (2006) 2.46
Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol (2010) 2.46
Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer. J Clin Oncol (2009) 2.44
Contemporary epidemiology of renal cell cancer. Cancer J (2008) 2.40
Phosphoinositide signalling in cancer: beyond PI3K and PTEN. Nat Rev Cancer (2010) 2.35
Adiponectin and cancer: a systematic review. Br J Cancer (2006) 2.33
Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer (2005) 2.33
Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol (2010) 2.31
Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol (2010) 2.26
Obesity as a major risk factor for cancer. J Obes (2013) 2.26
Amino acid signaling to mTOR mediated by inositol polyphosphate multikinase. Cell Metab (2011) 2.24
Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res (2008) 2.13
Body mass index and risk of lung cancer among never, former, and current smokers. J Natl Cancer Inst (2012) 2.13
Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. Cancer Res (2010) 2.13
Obesity, inflammation, and liver cancer. J Hepatol (2011) 2.09
Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann N Y Acad Sci (2012) 2.04
Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol (2008) 2.03
HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women. Diabetologia (2007) 2.03
Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients. J Natl Cancer Inst (2013) 1.96
Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol (2007) 1.96
Energy balance, host-related factors, and cancer progression. J Clin Oncol (2010) 1.85
Low-level human equivalent gestational lead exposure produces sex-specific motor and coordination abnormalities and late-onset obesity in year-old mice. Environ Health Perspect (2008) 1.84
Calorie restriction and cancer prevention: metabolic and molecular mechanisms. Trends Pharmacol Sci (2010) 1.82
The role of adiponectin in cancer: a review of current evidence. Endocr Rev (2012) 1.78
Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev (2008) 1.77
Obesity and cancer risk: recent review and evidence. Curr Oncol Rep (2011) 1.76
Promoting a healthy lifestyle among cancer survivors. Hematol Oncol Clin North Am (2008) 1.75
Risk of cancer following hospitalization for type 2 diabetes. Oncologist (2010) 1.75
S6K1 plays a critical role in early adipocyte differentiation. Dev Cell (2010) 1.74
The use of racial, ethnic, and ancestral categories in human genetics research. Am J Hum Genet (2005) 1.73
Metformin: a therapeutic opportunity in breast cancer. Clin Cancer Res (2010) 1.70
The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab (2010) 1.67
Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr Rev (2011) 1.65
Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol (2008) 1.64
Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring) (2009) 1.64
Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. Bioessays (2014) 1.64
Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma. Cancer Prev Res (Phila) (2010) 1.60
Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev (2013) 1.58
Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression. Exp Gerontol (2013) 1.57
Insulin and insulin resistance. Clin Biochem Rev (2005) 1.57
Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer. J Clin Oncol (2011) 1.56
Body fatness at young ages and risk of breast cancer throughout life. Am J Epidemiol (2010) 1.56
Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res (2012) 1.55
Adipocyte-derived endotrophin promotes malignant tumor progression. J Clin Invest (2012) 1.55
Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers. Carcinogenesis (2012) 1.52
Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice. Sci Signal (2012) 1.50
Sociodemographic, perinatal, behavioral, and psychosocial predictors of weight retention at 3 and 12 months postpartum. Obesity (Silver Spring) (2009) 1.50
Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev (2005) 1.49
Invited Commentary: Limitations and Usefulness of the Metabolically Healthy Obesity Phenotype. Am J Epidemiol (2015) 1.48
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer (2013) 1.47
p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer. Cancer Cell (2016) 1.47
Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev Res (Phila) (2012) 1.44
Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer (2005) 1.44
Role of autophagy in cancer prevention. Cancer Prev Res (Phila) (2011) 1.43
High-speed vibrational imaging and spectral analysis of lipid bodies by compound Raman microscopy. J Phys Chem B (2009) 1.43
Understanding obesity and endometrial cancer risk: opportunities for prevention. Am J Obstet Gynecol (2011) 1.42
Identifying patients with suspected renal tract cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract (2012) 1.42
Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice. PLoS One (2012) 1.41
Coherent anti-Stokes Raman scattering imaging of lipids in cancer metastasis. BMC Cancer (2009) 1.41
The association of body mass index and health-related quality of life in the general population: data from the 2003 Health Survey of England. Qual Life Res (2009) 1.40
Male breast carcinoma: increased awareness needed. Breast Cancer Res (2011) 1.40
Body mass index and mortality: results of a cohort of 184,697 adults in Austria. Eur J Epidemiol (2009) 1.40
Sphingolipid signaling in metabolic disorders. Cell Metab (2012) 1.37
Epidemic inflammation: pondering obesity. Mol Med (2008) 1.36
Physical activity, sedentary behavior, and endometrial cancer risk in the NIH-AARP Diet and Health Study. Int J Cancer (2009) 1.35
Lifestyle as risk factor for cancer: Evidence from human studies. Cancer Lett (2010) 1.35
Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study. Endocr Relat Cancer (2010) 1.35
Adipokines linking obesity with colorectal cancer risk in postmenopausal women. Cancer Res (2012) 1.35
The epidemiology of endometrial and ovarian cancer. Hematol Oncol Clin North Am (2011) 1.34
Obesity and endometrial cancer survival: a systematic review. Int J Obes (Lond) (2012) 1.32
Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer (2015) 1.32
Epidemiology and surveillance of hepatocellular carcinoma. Liver Cancer (2012) 1.32
BMI, all-cause and cause-specific mortality in Chinese Singaporean men and women: the Singapore Chinese health study. PLoS One (2010) 1.32
Physical activity, sedentary behaviours, and the prevention of endometrial cancer. Br J Cancer (2010) 1.31
Defining the pathway to insulin-like growth factor system targeting in cancer. Biochem Pharmacol (2010) 1.31
Amino acids activate mammalian target of rapamycin complex 2 (mTORC2) via PI3K/Akt signaling. J Biol Chem (2010) 1.30
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst (2005) 4.45
Overweight, obesity, and cancer risk. Lancet Oncol (2002) 4.44
Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2006) 4.17
Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2010) 3.98
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet (2009) 3.76
Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet (2003) 3.53
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37
A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res (2007) 3.08
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07
Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer. Hepatology (2014) 3.06
Consumption of vegetables and fruits and risk of breast cancer. JAMA (2005) 3.02
Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer (2004) 2.96
Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr (2009) 2.93
Prospective study of hyperglycemia and cancer risk. Diabetes Care (2007) 2.89
Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol (2013) 2.87
Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst (2011) 2.63
Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr (2008) 2.53
Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2010) 2.47
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45
Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. Int J Epidemiol (2010) 2.44
Fruit and vegetable intake and mortality from ischaemic heart disease: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart study. Eur Heart J (2011) 2.42
Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev (2002) 2.42
Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr (2008) 2.35
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med (2008) 2.33
Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev (2005) 2.24
Air pollution and risk of lung cancer in a prospective study in Europe. Int J Cancer (2006) 2.17
The evaluation of the diet/disease relation in the EPIC study: considerations for the calibration and the disease models. Int J Epidemiol (2008) 2.11
Validation and calibration of food-frequency questionnaire measurements in the Northern Sweden Health and Disease cohort. Public Health Nutr (2002) 2.10
Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst (2011) 2.09
Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut (2011) 2.03
N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort. Cancer Epidemiol Biomarkers Prev (2013) 2.01
Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study. Am J Clin Nutr (2012) 1.98
Validity of a short questionnaire to assess physical activity in 10 European countries. Eur J Epidemiol (2011) 1.95
Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ (2011) 1.94
Obesity and colon cancer: does leptin provide a link? Int J Cancer (2004) 1.89
Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res (2007) 1.82
The role of smoking and diet in explaining educational inequalities in lung cancer incidence. J Natl Cancer Inst (2009) 1.81
Weight control and physical activity in cancer prevention. Obes Rev (2002) 1.79
Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2010) 1.78
Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet (2013) 1.78
Meat consumption and mortality--results from the European Prospective Investigation into Cancer and Nutrition. BMC Med (2013) 1.77
Body mass index and the risk for Crohn's disease and ulcerative colitis: data from a European Prospective Cohort Study (The IBD in EPIC Study). Am J Gastroenterol (2013) 1.77
Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. J Clin Endocrinol Metab (2006) 1.71
Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study. J Clin Oncol (2012) 1.70
Weight control and physical activity in cancer prevention: international evaluation of the evidence. Eur J Cancer Prev (2002) 1.68
Genetic variation in the HSD17B1 gene and risk of prostate cancer. PLoS Genet (2005) 1.67
Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays. Cancer Epidemiol Biomarkers Prev (2005) 1.67
Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study. PLoS Med (2012) 1.67
Fiber intake and total and cause-specific mortality in the European Prospective Investigation into Cancer and Nutrition cohort. Am J Clin Nutr (2012) 1.66
Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer (2008) 1.65
Progestins and progesterone in hormone replacement therapy and the risk of breast cancer. J Steroid Biochem Mol Biol (2005) 1.65
Biomarkers of oxidative stress and risk of developing colorectal cancer: a cohort-nested case-control study in the European Prospective Investigation Into Cancer and Nutrition. Am J Epidemiol (2012) 1.65
Serological markers predict inflammatory bowel disease years before the diagnosis. Gut (2012) 1.64
Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer (2007) 1.64
Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Cancer Lett (2011) 1.62
Plasma carotenoids and vitamin C concentrations and risk of urothelial cell carcinoma in the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr (2012) 1.61
Coffee consumption and risk of chronic disease in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany study. Am J Clin Nutr (2012) 1.61
Serum enterolactone and prognosis of postmenopausal breast cancer. J Clin Oncol (2011) 1.60
EPIC-Heart: the cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries. Eur J Epidemiol (2007) 1.59
Estimation of the intake of anthocyanidins and their food sources in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Nutr (2011) 1.56
Pregnancy loss and risk of cardiovascular disease: a prospective population-based cohort study (EPIC-Heidelberg). Heart (2010) 1.56
Physical activity and risk of colon and rectal cancers: the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev (2006) 1.56
Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Arch Physiol Biochem (2009) 1.55
No association of consumption of animal foods with risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.55
Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2006) 1.55
Longitudinal changes in weight in relation to smoking cessation in participants of the EPIC-PANACEA study. Prev Med (2011) 1.55
Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). Am J Clin Nutr (2010) 1.53
Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk. Cancer Res (2012) 1.52
Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer (2004) 1.52
Breast cancer risk in relation to abortion: Results from the EPIC study. Int J Cancer (2006) 1.51
Validity of multiplex-based assays for cytokine measurements in serum and plasma from "non-diseased" subjects: comparison with ELISA. J Immunol Methods (2009) 1.50
IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS One (2008) 1.50
Intake of vegetables, legumes, and fruit, and risk for all-cause, cardiovascular, and cancer mortality in a European diabetic population. J Nutr (2008) 1.49
Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2007) 1.49
Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden. Oncol Rep (2003) 1.48
Alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Am J Clin Nutr (2011) 1.48
Within- and between-cohort variation in measured macronutrient intakes, taking account of measurement errors, in the European Prospective Investigation into Cancer and Nutrition study. Am J Epidemiol (2004) 1.48
Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Cancer Causes Control (2007) 1.48
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet (2012) 1.47
Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort. Int J Cancer (2006) 1.43
Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Int J Cancer (2003) 1.42
Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis. Breast Cancer Res Treat (2010) 1.41
High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort. J Clin Oncol (2004) 1.41
Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3. PLoS One (2011) 1.41
Lifestyle risk factors and residual life expectancy at age 40: a German cohort study. BMC Med (2014) 1.41
Lung cancers attributable to environmental tobacco smoke and air pollution in non-smokers in different European countries: a prospective study. Environ Health (2007) 1.41
Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer (2010) 1.40
Physical Activity and Mortality in Individuals With Diabetes Mellitus: A Prospective Study and Meta-analysis. Arch Intern Med (2012) 1.38
Physical activity and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev (2006) 1.38
The association of education with body mass index and waist circumference in the EPIC-PANACEA study. BMC Public Health (2011) 1.38
Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Res (2012) 1.37
Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study. Endocr Relat Cancer (2010) 1.35
Plasma leptin and breast cancer risk: a prospective study in northern Sweden. Breast Cancer Res Treat (2004) 1.35
Circulating C-reactive protein concentrations and risks of colon and rectal cancer: a nested case-control study within the European Prospective Investigation into Cancer and Nutrition. Am J Epidemiol (2010) 1.34